TB-500 10mg

Description

Buy TB-500 10mg with the documents you can inspect

Buy TB-500 10mg from Purity Collective in a lyophilized vial for qualified laboratory research. This page connects the catalog identity, listed quantity, SKU and available analytical records so a purchasing team can assess the listing before ordering without relying on mechanism claims, human outcomes or blanket testing promises.

Good documentation does more than display a percentage. It lets the reviewer compare the compound, lot, method, dates, specification and result while keeping any discrepancy visible. Measurements from one submitted sample describe that sample only, and a laboratory result should not be interpreted beyond the fields printed in its report.

Product details

Available analytical documents

Open the TB-500 10mg UPLC/MS report and the TB-500 endotoxin report to inspect the complete records. Purity Collective’s guide to reading a peptide COA explains how to review identity, lot, method, chronology, specification and result fields, while the TB-500 research guide explains how this listing fits within the broader TB-500 documentation cluster.

The UPLC/MS report identifies TB-500 and lot PCCL-4131262. For its submitted sample, it records a measured quantity of 9.91mg against a 10mg specification and a purity result of 99.25% against a greater-than-98% specification. The report lists March 15, 2026 as the received date and March 22, 2026 as the analysis date.

The separate endotoxin document uses the related lot identifier PCCL-4131262-E and records a result below 0.05 EU/mL. It does not print an endotoxin acceptance specification. It also lists April 3, 2026 as the analysis date and April 8, 2026 as the received date, placing the stated analysis five days before receipt. Because of those limitations, this page does not label the result as a pass or use it to establish sterility, safety, suitability or performance.

Keep the chronology in the purchasing record

A transparent product review should preserve a document’s limitations along with its measurements. The listed 10mg quantity is a catalog fact; 9.91mg and 99.25% are results for the submitted UPLC/MS sample. The endotoxin result belongs to its separate `-E` document and should be evaluated only after the chronology and acceptance criteria are resolved under the laboratory’s own procedures.

Before you order

• Confirm that TB-500, the 10mg listed quantity and SKU PC-TB-500-10MG match the procurement request.
• Review both reports in full, including the base and `-E` lot identifiers, methods, dates, specifications and results.
• Keep the 9.91mg and 99.25% measurements tied to the submitted UPLC/MS sample.
• Record that the endotoxin document lists analysis before receipt and prints no acceptance specification.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

TB-500 10mg FAQs

What is included in this TB-500 10mg listing?

The listing identifies TB-500 with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-TB-500-10MG for qualified laboratory research.

Which analytical documents are available?

The page links directly to a two-page UPLC/MS report and a separate endotoxin report. Each should be reviewed as a complete record, including its compound, lot, method, dates, specifications and results.

What does the TB-500 UPLC/MS report show?

For submitted lot PCCL-4131262, the report records a measured quantity of 9.91mg and a purity result of 99.25%. These are sample-specific measurements, not universal guarantees.

What limitations apply to the endotoxin report?

The document uses lot PCCL-4131262-E, records a result below 0.05 EU/mL without an acceptance specification, and lists analysis five days before receipt. This page therefore does not call the result a pass.

Is TB-500 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.